Share on StockTwits

Omnicell (NASDAQ:OMCL) Director James T. Judson unloaded 5,000 shares of the stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $28.18, for a total transaction of $140,900.00. Following the completion of the sale, the director now directly owns 13,981 shares in the company, valued at approximately $393,985. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of research firms have recently commented on OMCL. Analysts at Topeka Capital Markets raised their price target on shares of Omnicell from $30.00 to $31.00 in a research note on Thursday, August 28th. They now have a “buy” rating on the stock. Separately, analysts at Zacks upgraded shares of Omnicell from a “neutral” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $32.00 price target on the stock. Seven analysts have rated the stock with a buy rating, Omnicell has an average rating of “Buy” and an average price target of $31.43.

Shares of Omnicell (NASDAQ:OMCL) traded up 0.46% on Thursday, hitting $28.27. The stock had a trading volume of 54,080 shares. Omnicell has a one year low of $20.88 and a one year high of $30.33. The stock’s 50-day moving average is $27. and its 200-day moving average is $27.55. The company has a market cap of $1.014 billion and a price-to-earnings ratio of 36.17.

Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, July 31st. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.29 by $0.01. The company had revenue of $105.10 million for the quarter, compared to the consensus estimate of $103.23 million. During the same quarter last year, the company posted $0.27 earnings per share. Omnicell’s revenue was up 12.2% compared to the same quarter last year. Analysts expect that Omnicell will post $1.23 EPS for the current fiscal year.

Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.